Literature DB >> 28679351

Modulatory effects of quercetin on liver histopathological, biochemical, hematological, oxidative stress and DNA alterations in rats exposed to graded doses of score 250.

Sabrine Kasmi1, Intithar Bkhairia2, Bahira Harrabi1, Hela Mnif3, Rim Marrakchi4, Hanen Ghozzi1, Choumous Kallel5, Moncef Nasri2, Khaled Zeghal1, Kamel Jamoussi4, Ahmed Hakim1.   

Abstract

This study investigated the morphological, biochemical and molecular aspects of liver injury in rats after the exposure to difenoconazole and the protective effects of quercetin against hepatotoxicity and genotoxicity induced by this fungicide. Rats were given graded doses of difenoconazole associated or not to quercetin daily for 20 days. Our results showed a significant increase in PLT (platelets) and WBC (white blood cells) in rats treated with higher doses of difenoconazole (1/38 and 1/9 of LD50). However, a significant decrease in Hb (hemoglobin) rate and RBC (red blood cells) number in rats treated with higher doses of difenoconazole (1/38 and 1/9 of LD50) was obtained. Besides, difenoconazole treatment caused an increase in hepatic enzyme activities of alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP) and lactate dehydrogenase (LDH). Difenoconazole increased the levels of malondialdehyde (MDA) and advanced oxidation protein products (AOPPs), and decreased superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) activities and vitamin C levels in liver tissues compared to the control group. We also noted a degradation of nucleic acids, testifying difenoconazole genotoxicity. Changes in hepatic tissues were confirmed by histological findings. Co-administration of quercetin (20 mg/kg) improved hematological and biochemical parameters and showed a significant liver protective effect by decreasing MDA levels and producing advanced oxidation protein, along with increased antioxidative enzyme activities and vitamin C levels. Results were confirmed by the improvement of histological impairments. Thus, it appears that quercetin was effective in preventing acute liver injury induced by exposure to difenoconazole.

Entities:  

Keywords:  Quercetin; biochemical parameters; difenoconazole; hematological parameters; liver; oxidative stress

Mesh:

Substances:

Year:  2017        PMID: 28679351     DOI: 10.1080/15376516.2017.1351507

Source DB:  PubMed          Journal:  Toxicol Mech Methods        ISSN: 1537-6516            Impact factor:   2.987


  6 in total

1.  Biosafety evaluation of two Beauveria bassiana products on female albino rats using acute oral test.

Authors:  Sahar Sayed Ali; H M El-Saadany; Gamila A M Kotb; Nashwa Elshaer; Sahar J Melebary; Soliman M Soliman; Ahmed A Gh Farag
Journal:  Saudi J Biol Sci       Date:  2022-04-21       Impact factor: 4.052

Review 2.  Reactive oxygen species in cancer: a paradox between pro- and anti-tumour activities.

Authors:  Romina Kohan; Alejandro Collin; Solange Guizzardi; Nori Tolosa de Talamoni; Gabriela Picotto
Journal:  Cancer Chemother Pharmacol       Date:  2020-06-22       Impact factor: 3.333

3.  Quercetin increases the antioxidant capacity of the ovary in menopausal rats and in ovarian granulosa cell culture in vitro.

Authors:  Jiao Wang; Xin Qian; Qiang Gao; Chunmei Lv; Jie Xu; Hongbo Jin; Hui Zhu
Journal:  J Ovarian Res       Date:  2018-06-21       Impact factor: 4.234

Review 4.  Glutathione depleting drugs, antioxidants and intestinal calcium absorption.

Authors:  Luciana Moine; María Rivoira; Gabriela Díaz de Barboza; Adriana Pérez; Nori Tolosa de Talamoni
Journal:  World J Gastroenterol       Date:  2018-11-28       Impact factor: 5.742

5.  Cross-resistance of the pathogenic fungus Alternaria alternata to fungicides with different modes of action.

Authors:  Li-Na Yang; Meng-Han He; Hai-Bing Ouyang; Wen Zhu; Zhe-Chao Pan; Qi-Jun Sui; Li-Ping Shang; Jiasui Zhan
Journal:  BMC Microbiol       Date:  2019-09-02       Impact factor: 3.605

6.  Effects of Quercetin Supplementation on Hematological Parameters in Non-Alcoholic Fatty Liver Disease: a Randomized, Double-Blind, Placebo-Controlled Pilot Study.

Authors:  Yahya Pasdar; Farhad Oubari; Mahin Nikougoftar Zarif; Mehrnaz Abbasi; Azizollah Pourmahmoudi; Mahboobe Hosseinikia
Journal:  Clin Nutr Res       Date:  2020-01-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.